Use of recombinant factor VIIa for refractory hemorrhage during extracorporeal membrane oxygenation

Pediatric Critical Care Medicine

Volumn 6, Issue 3, 2005, Pages 348-351

  Dominguez, T E ^a   Mitchell, M ^a   Friess, S H ^a   Huh, J W ^a   Manno, C S ^a   Ravishankar, C ^a   Gaynor, J W ^a   Tabbutt, S ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Blood coagulation disorders; Cardiopulmonary bypass; Case report; Extracorporeal membrane oxygenation; Factor VIIa; Hemorrhage

Indexed keywords

AMINOCAPROIC ACID; APROTININ; HEPARIN; NITRIC OXIDE; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADOLESCENT; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; BLOOD VOLUME; CANNULATION; CASE REPORT; CONGESTIVE CARDIOMYOPATHY; DISEASE SEVERITY; DRUG EFFICACY; EXTRACORPOREAL OXYGENATION; FATALITY; HEART TRANSPLANTATION; HEMOSTASIS; HIGH FREQUENCY VENTILATION; HUMAN; INTENSIVE CARE; MALE; PNEUMOTHORAX; POSTOPERATIVE CARE; PRIORITY JOURNAL; RESPIRATORY FAILURE; SCHOOL CHILD; THORAX DRAINAGE; THROMBOSIS; TREATMENT OUTCOME;

ADOLESCENT; CHILD; EXTRACORPOREAL MEMBRANE OXYGENATION; FACTOR VII; HEMORRHAGE; HEMOSTATICS; HUMANS; INTENSIVE CARE UNITS, PEDIATRIC; MALE; RECOMBINANT PROTEINS;

EID: 19444375493     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PCC.0000161623.51275.0F     Document Type: Article

References (18)

1. Muntean W: Coagulation and anticoagulation in extracorporeal membrane oxygenation. Artif Organs 1999; 23:979-983
2. Atkinson JB, Kitagawa H, Humphries B: Major surgical intervention during extracorporeal membrane oxygenation. J Pediatr Surg 1992; 27:1197-1198
3. Mehta U, Laks H, Sadeghi A, et al: Extracorporeal membrane oxygenation for cardiac support in pediatric patients. Am Surg 2000; 66:879-886
4. Dutton RP, Hess JR, Scalea TM: Recombinant factor VIIa for control of hemorrhage: Early experience in critically ill trauma patients. J Clin Anesth 2003; 15:184-188
5. Hendriks HG, Meijer K, De Wolf JT, et al: Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: A pilot study. Transplantation 2001; 71:402-405
6. Hendriks HG, van der Maaten JM, de Wolf J, et al: An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII. Anesth Analg 2002; 93:287-289
7. Meijer K, Hendriks HG, De Wolf JT, et al: Recombinant factor VIIa in orthotopic liver transplantation: influence on parameters of coagulation and fibrinolysis. Blood Coagul Fibrinolysis 2003; 14:169-174
8. Tanaka KA, Waly AA, Cooper WA, et al: Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven). Anesthesiology 2003; 98:1513-1515
9. Bui JD, Despotis GD, Trulock EP, et al: Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII. J Thoracic Cardiovasc Surg 2002; 124:852-854
10. Hoffman M, Monroe DM III, Roberts HR: Activated factor VII activates factors IX and X on the surface of activated platelets: Thoughts on the mechanism of action of high-dose activated factor VII. Blood Coagul Fibrinolysis 1998; 9(Suppl 1):S61-S65
11. Almeida AM, Khair K, Hann I, et al: The use of recombinant factor VIIa in children with inherited platelet function disorders. Br J Haematol 2003; 121:477-481
12. Chuansumrit A, Treepongkaruna S, Phuapradit P: Combined fresh frozen plasma with recombinant factor VIIa in restoring hemostasis for invasive procedures in children with liver diseases. Thromb Haemost 2001; 85:748-749
13. Tobias JD, Groeper K, Berkenbosch JW: Preliminary experience with the use of recombinant factor VIIa to treat coagulation disturbances in pediatric patients. South Med J 2003; 96:12-16
14. Tobias JD, Berkenbosch JW, Russo P: Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant. Pediatr Crit Care Med 2003; 4:49-51
15. Pychynska-Pokorska M, Moll JM, Krajewski W, et al: The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. Pediatr Crit Care Med 2004; 5:234-239
16. Cheung PY, Sawicki G, Salas E, et al: The mechanisms of platelet dysfunction during extracorporeal membrane oxygenation in critically ill neonates. Crit Care Med 2000; 28:2584-2590
17. Divanon F, Hecquard C, Borel-Derlon A: Experience with use of recombinant activated factor VII. J Clin Pharm Ther 2002; 27: 133-138
18. Roberts HR: Recombinant factor VIIa (Novoseven) and the safety of treatment. Semin Hematol 2001; 38(4 Suppl 12):48-50